Objective: To investigate effect of warm ischemia after cardiac death on activation of TLR9 pathway in porcine liver. Methods: Donor of cardiac death (DCD) model was established with Duroc, Landrace, Large White crossbred pigs. Liver tissues from the animals were harvested at 0, 5, 10, 15, 25 and 30 minutes after warm ischemia for analysis of expression of TLR9, IRF7, IFN-β, and TNF-α at mRNA and protein levels by real-time PCR and western blot, respectively, and for assessment of NF-κB/DNA binding activity by western blot detection of p65 protein.
Prevention of TLR9 Pathway in

Introduction
Warm ischemia injury is closely related to postoperative complications and prognosis in liver transplantation [1] , which can be divided into ischemia phase and reperfusion injury phase [2] . During the pathological process of warm ischemia injury, damage mainly occurs in the reperfusion phase [3] . Interruption of the source of oxygen and nutrients and accumulation of metabolites in the warm ischemia phase will inevitably lead to dysfunction of cells and subcellular organs, such as mitochondrial dysfunction, impaired membrane function, etc [4] , while breakdown products from dead cells causes damage to Kupffer cells, neutrophil and activation of platelet, which results in consequent release of large amounts of proinflammatory cytokines, such as TNF-α, IL-1β, IL-6, IL-10, etc. It is known that inflammatory cytokines released from the dead cells in the liver cause cell damage individually or synergistically [5, 6] . For example, TNF-α can directly lead to sinusoidal endothelial cell swelling; and cause liver microcirculation barrier by mediating interaction between neutrophils and sinusoidal endothelial cells, which in turn aggravates liver ischemia and hypoxia [1] . Apoptosis and oxidative stress were reported to play important pathological roles as well during the reperfusion injury. The anit-inflammatory, anti-apoptosis, and antioxidative stress activities of propofol, sevoflurane, or delta-9-tetrahydrocannabinol (a kind of cannabinoid agonist) could protect effectively the reperfusion-induced hepatic injury [6, 7] . In addition, protein tyrosine phosphatase receptor-type O (PTPRO) may play a critical role because overexpression of PTPRO strongly downregulates both clinical and experimental liver fibrosis by affecting PDGF signaling [8] .
The most prominent changes in liver tissue of warm ischemia are inflammation of hepatocytes, but the underlying mechanisms are unclear so far. Studies have found that Toll like receptors (TLRs), an important component of the innate immune system can mediate ischemic injury [1] . Among the 13 TLRs, TLR9 is expressed on dendritic cells, B cells and macrophages and other immune cells [3] . It can be activated by either pathogen ligands or DNA fragments produced after tissue damage [9] . TLR9 is initially localized within the cytoplasm endoplasmic reticulum, transported to lysosomes by virtue of the membrane protein NC9381, then binds to CpG DNA and recruit the adapter molecule MyD88 complex to form TLR9 complex (TLR9-MyD88-IRAK4-TRAF6) [10] . IRAK4 in the complex phosphorylates IRAKl, and activates transcription factor NFκB (nuclear factor kappa B) or IRF7 pathway to induce production of pro-inflammatory cytokines such as TNF-α and IFN-β [3] .
Kupffer cells, liver dendritic cells, NK cells and hepatic stellate cells all express TLR9 [11] . In addition, TLR9 down-regulates the expression of inflammatory cytokines including TNF-α and IL-6 and diminishes ischemia-reperfusion induced hepatic injury in mice [1] . However, the exact underlying mechanisms are unknown. Herein we reported that warm ischemia activated TLR9 signaling pathways via TNF-α and IFN-β molecules in a porcine liver transplant DCD (donor after cardiac death) model, and prevention of the TLR9 pathway by iCpG provided protection of hepatocytes from ischemia-reperfusion injury.
Materials and Methods
Animals
Experimental pigs with balanced gender (Duroc, Landrace, Large White crossbred pigs, provided by the Shenyang Agricultural University), weighing 25 ~ 30kg, were bred following regulations of animal welfares.
Establishment of DCD model and collection of samples
Prior to surgery, the animals were fasted for 24 hours. One hour prior to surgery, the animals were intravenously injected with 0.1ml/kg of TRL9 inhibitor, i.e., inhibitory cytosine-guanosine dinucleotide (ODN2088, Invivogen), or intravenously injected with same amount of negative control for inhibitory oligonucleotide for murine specific CpGs (ODN 2088 Control, Invivogen). After anesthesia, overdose of muscle relaxants was given intravenously for making class 3 Maastricht DCD model by way of "asphyxiation" method [12, 13] . Briefly, after dissection of the first hepatic porta, the common bile duct was resected on the upper edge of duodenal bulb, followed by dissection of hepatic artery and portal vein from their celiac artery and superior mesenteric confluence, respectively, upward to their entering into the liver. After sampling of abdominal aorta with 40 ml of blood for baseline data, intravenous pancuronium at 60-100 μg/kg was injected, with the ventilator stopped and immediate intravenous heparin at 3 mg/kg). After meeting the 
Real-time PCR
Expression of TLR9, TNF-α, IRF7, and INF-β mRNA was assessed by real-time PCR. Primer pairs: TLR9, forward 5′-tgcaggagctgaacatgaac-3′, reward 5′-attggacaggtccacaaagc-3′;TNF-α, forward 5′-aaccaaacctgtgccttgtc-3′, reward 5′-atacacccacacaccccact-3′;IRF-7, forward 5′-tctggatgaagctgatgcac-3′, reward 5′-agggtcccctgagttgtctt-3′;INF-β forward 5′-ctgccctctccatcgactac-3′, reward 5′-acccagtgctggagaaattg-3′, with β-actin mRNA level as an internal control.
Total tissue RNA was isolated from 0.1 to 0.5 g of fresh liver tissue by using TREzol (Invitrogen, USA). After reverse transcription by M-MLV RT (M-MLV, Promega, the cDNA products were used for PCR on qRT-PCR cycler (Light Cycler, Roche Diagnostics, Mannheim, Germany): 50℃ 2 min ,95℃10 min; 95℃ 15 sec, 60℃ 1 min, 40 cycles; 95℃ 15sec, 60℃ 15 sec, 95℃ 15 sec.
Western blot
Cytoplasmic and nuclear proteins were prepared with Subcellular Protein Fractionation Kit (Pierce, USA) and quantified with BCA kit (Pierce, USA). Expression of TLR9, TNF-α, IRF7, IFN-βin 20 µg of prepared proteins was analyzed by western blot, using primary and secondary antibodies (Santa Cruz, USA). Grey gradient analysis of signal density was done with LabWorks program. 
Histology and transmission electron microscope examination
Snap frozen liver tissues were submitted for H&E staining and microscope examination. Electron microscope examination of fresh liver tissues were performed at the Electronic Miscopy Center of our institute after fixation in 2% paraformaldehyde.
Liver enzyme
Serum aminotransferase (ALT) was determined by ELISA prior to and 20 minutes post ischemia.
Hepatic oxygen tension analysis
Blood samples were collected from pig hepatic artery at the time 0 (before ischemia), 5, 10, 15, 20 min of the warm ischemia (see the Establishment of DCD model and collection of samples). Each 10 µl plasma was absorbed into an i-STAT Test Cartridge (CG4+; Abbott Point of Care Inc, Princeton, NJ) for partial pressure of oxygen (PaO 2 ) analysis by an i-STAT Portable Blood Gas Analyzer (i-STAT; Abbott Point of Care Inc, Princeton,
NJ).
Electron microscopy 5 mm in diameter samples of liver biopsy were fixed in Trump's fixative (postfixed in 1% osmium tetroxide with sodium cacodylate buffer) for 3 h at 20•C, and stained en bloc with 5% aqueous uranyl acetate. Thick sections (1 µm) were then stained with toluidine blue. Thinner sections of 50-70 nm were cut from the stained sample with a LKB8801 ultramicrotome (LKB, Stockholm, Sweden), and stained with uranyl acetate and lead citrate. All samples were then examined and photographed with transmission electron microscope (Philips EM 201).
Statistics
Data was analyzed with SPSS 16.0 software and presented as mean ± SD. One-Way ANOVA was used for intergroup comparison, Student-Newman-Keul (sSNK) test for intragroup comparison, and IndependentSample T Test for comparison between two groups.
Results
Expression of TLR9, IRF7, TNF-α, IFN-β in liver tissue after warm ischemia
We first assessed the TLR9 pathway molecules at mRNA levels. The real-time PCR data showed that TLR9, IRF7, TNF-α, and IFN-β mRNA levels in the donor liver increased along prolonged warm ischemia. The TLR9 and IRF7 mRNA both significantly increased after 10 minutes of ischemia, compared to that at baseline (p < 0.0001), while increase of TNF-α and IFN-β mRNA in the donor organ began to appear at 15 and 20 minutes of ischemia compared to the levels of time 0, respectively (p < 0.0001). In addition, at 15 and 20 minutes of ischemia, increase of TNF-α mRNA in the liver tissue was more prominent than IFN-β mRNA did (t test, * p < 0.05 vs 0 min group, ** p < 0.01 vs 0 min group, Fig. 1A ). More important, blocking of TLR9 pathway with iCpG remarkably prevented ischemia-induced upregulation of IRF7, TNF-α, IFN-β mRNA (t test, *p < 0.05 vs 0 min group, ** p < 0.01 vs 0 min group, Fig. 1B) .
Next, we examined expression of the TLR9 pathway molecules at protein level by western blot. Consistent with our observations with real-time PCR, warm ischemia induced significant expression of TLR9 pathway proteins in a time dependent manner and at the pace of mRNA expression ( Fig. 2A) . Again, TNF-α and IFN-β protein expression was 5 minutes behind TLR9 and IRF7 expression, and elevation of TNF-α protein level was earlier than IFN-β protein did (t test, * p < 0.05 vs 0 min group, ** p < 0.01 vs 0 min group). In line with our results of mRNA studies above, administration of iCpG effectively inhibited overexpression of IRF7, TNF-α, IFN-β proteins after ischemia (Fig. 2B and 2C , ** p < 0.01).
Histological change of the liver tissue of the treated animals were examined as well. Histopathologically, only mild swollen hepatocytes were observed around the central vein prior to ischemia in iCpG-treated samples (Fig. 3A) compared to the iCpG pretreated animals without ischemia (Fig. 3B) . However, focal necrosis (universally severe swollen hepatocytes with enlarged nuclei) were presented in the liver tissue from the animals pretreated with the negative control agent (Fig. 3C) after ischemia, which was not observed in normal controls (Fig. 3D) . This result demonstrated that pretreatment with iCPG alleviated ischemia-caused liver damage.
We further observed ultrastructural features of the liver tissue after ischemia with or without iCpG pretreatment. As shown in Figure 4 , no difference existed between ultrastructural characteristics of liver tissues from the control group (Fig. 3D) and those from the iCpG group (Fig. 3B) , prior to ischemia. However, 20 minutes after ischemia, severe tissue damage including pyknosis, karyorrhexis, and nuclear/plasma membrane melting were presented in the ischemia alone group (Fig. 4C) . In the meantime, only mild shrinkage of nuclei, condensation, and margination of chromatin was presented after pre-treatment with iCpG (Fig. 4A) . These results indicated that prohibition of TLR9 pathway with iCpG clearly prevented hepatocyte damage induced by warm ischemia.
In order to evaluate post-ischemia liver function, serum ALT was measured in the animals. The results revealed that ALT elevated 20 minutes after ischemia in both control and iCpG groups (p < 0.001, paired t-test), while to a much lower level in iCpG group than that in the control group (Fig. 5, p < 0.01, t-test) . In addition, a hepatic oxygen tension analysis was performed in a time course during warm ischemia, which showed that the partial pressure of oxygen (PaO 2 ) levels of iCpG-treated samples at 5 and 10 min after ischemia were obviously higher than that of non-treatment controls. There were no different at 15 and 20 min after warm ischemia (Fig. 6) . It suggested that inhibition of TLR9 pathway by iCpG significantly released the hepatic oxygen delivery.
Discussion
TLRs are important components of the innate and adaptive immune systems and play key role in initiation of immune response [15] . Among the TLRs mediating inflammation, TLR2, TLR4 and TLR9 are related to ischemic injury [16] . Previous studies have demonstrated the involvement of TLR2 and TLR4 in hepatic ischemia [1] , but the role of TLR9 in liver ischemia is not clear yet. Our results indicated that warm ischemia activated TLR9 pathways in a time dependent manner and blocking this pathway using iCpG reduced ischemia-induced tissue damage in the liver. Our results suggest that TLR9 signaling pathway is involved in ischemic damage of donor liver.
Activation of TLR9 signals two pathways: the TLR9-NFκB-TNF-α pathway and the TLR9-IRF7-IFN-β pathway [17] . In this study, by using porcine liver warm ischemia model, we observed elevated expression of all these signal pathway molecules during the 30-minute warm ischemia period, indicating activation of both pathways.
It is well known that NF-κB is constantly functional in the cell as a transcription factor protein [18] . In resting cells, NF-κB and IκB form an inactive cytoplasm complex. Upon stimulation by extracellular signals such as activation of TLR receptors, IκB kinase complex (IκB kinase, IKK) phosphorylates IκB, enabling exposure of the nuclear localization sites of NF-κB [19] . The free cytoplasmic NF-κB protein rapidly moves to the nucleus, binds to specific κB sequences, and induces transcription of TNF-α and other inflammatory mediators [14] . As the main subunit of NF-κB, P65 promotes gene transcription in TLR9 pathways and participates in the subsequent cytokine cascade [20] . From this point of view, activation of p65 reflects activity of NF-κB [21] . In the present study, we found that ischemia induced expression of p65 expression and we believed that hepatic ischemia activated the downstream NF-κB pathway.
Our results also showed that at 15 and 20 min of hepatic ischemia, expression of TNF-α was significantly higher than that of IFN-β, indicating an earlier and stronger activation of TLR9-NFκB-TNF-α pathway over TLR9-IRF7-IFN-β pathway. This finding is consistent with results from previous study [22] . It has been shown that TNF-α is an important mediator of inflammation after acute ischemic injury [23] . TNF-α stimulates expression of tissue factor and leukocyte adhesion molecules, promotes release of interleukin-1, nitric oxide, von Willebrand factor VIII, platelet-activating factor and endothelin, and reduces production of tissue plasminogen activator, thereby reducing the release of plasminogen activator inhibitor-1 [24] . TNF-α also induces xanthine oxidase, cyclooxygenase, and nicotinamide adenine dinucleotide phosphate oxidase. Through these activities, TNF-α irrigates local blood vessels, promotes inflammation, thrombosis and bleeding in these vessels, which contribute to pathogenesis of ischemic injury [25] .
Studies have shown that IFN-β has not only anti-viral activities but also antiinflammatory functions by reducing intracellular active oxide species [26] . We found that expression of IFN-β in the ischemic tissue was increased later along elongation of ischemia time, indicating that IFN-β may play a role in late stage of ischemic injury.
Synthetic iCpG is an inhibitory cytosine-guanosine dinucleotide competing with endogenous CpG for binding sites on TLR9 to inhibit TRL9 pathway [12] . Our data form Western blot shown that iCpG significantly suppressed the downstream molecules of the TLR9 pathway including IRF7 and NF-κB. This could the therapeutic mechanisms of iCpG in the study, reflected by reduction of ischemia-reperfusion cytokines TNF-α and IFN-β and histopathological and enzymatic protection effects.
Conclusion
In summary, warm ischemia could activate TRL9 pathway in a porcine DCD liver transplantation model. Intravenous injection of iCpG could attenuate warm ischemia caused liver tissue damage by specifically blocking TLR9 pathway.
